|
CV Information
 DR. NOR EFFA SYAZULI BINTI ZULKAFLI
| |
|---|---|
|
Start Year, Student Name, Category, Mode, Thesis Title, Supervisor Type
| |
| 1 | 2024, ABDULRAHEEM MUSTAFA N ABDULRAHEEM, PHD, RESEARCH - FULL TIME, In Silico And Ex Vivo Evaluations Of Novel Immune Checkpoints Expressed By Foxp3+ T-Regulatory Cells As Putative Drug Candidates In Disease Models, MAIN SUPERVISOR |
| 2 | 2024, MUSTAFA SHEVAN MOHAMMED MUSTAFA, PHD, RESEARCH - FULL TIME, Study of Prevalence of Alloantibody Amongst Thalesemia, Leukaemia Patients and Pregnant Woman., CO-SUPERVISOR |
| 3 | 2023, AL DAFFAIE SAHAR TAHA HATIF, PHD, RESEARCH - FULL TIME, Elucidating The Crosstalk Between Melanocyte-Stimulating Hormone (MSH) Isoforms and Foxp3+ T Cell Regulatory Properties Among Autoimmune Vitiligo Patients., MAIN SUPERVISOR |
| 4 | 2023, KHALAF NOORULHUDA FAKHRI KHALAF, PHD, RESEARCH - FULL TIME, Molecular Understanding HLA-G in Type 2 Diabetes Mellitus and Its Putative Immune Modulators in Disease Development and Complications Among Iraqi Population., MAIN SUPERVISOR |
| 5 | 2023, HAMAD AHMED GHAZI HAMAD, PHD, RESEARCH - FULL TIME, Elucidating The Role Of Microrna155 In Regulating Gut Microbiota Compositions And Cytokine Expressions Among Irritable Bowel Syndrome Patients Of Iraqi Population., MAIN SUPERVISOR |
| 6 | 2021, YANG SHAOLONG, PHD, RESEARCH - FULL TIME, A Proposal to Research the effect of mesenchymal stem cells on type 1 diabetes mellitus., CO-SUPERVISOR |
| 7 | 2021, MAJEED ABDULRAHEEM YOUSIF MAJEED, PHD, RESEARCH - FULL TIME, Immune Markers Dysregulation and Their Association with Interferon Induced Helicase-1 Polymorphism in Patients with Mild/Moderate Coronavirus Disease 2019, MAIN SUPERVISOR |
| 8 | 2020, KOMATHI A/P SELVARAJAH, PHD, RESEARCH - FULL TIME, Differentiation of Human Induced Pluripotent Stem Cells for Corneal Epithelial-like Formation and Immunobiology of HSV-1 Infective Keratitis on Experimental Model of Cornea, CO-SUPERVISOR |
| 9 | 2019, KALIDASAN A/L VASODAVAN, PHD, RESEARCH - FULL TIME, Investigating the Antiviral Activity of CRISPR-Mediated Upregulation (CRISPRa) of SLFN11 and CDKN1A Against HIV-1 Infected Cells, CO-SUPERVISOR |